At the Bedside: Houston attorney shares her story of living with sickle cell anemia
From the outside, there is nothing about successful, busy attorney Brenda Adimora that hints at a disease she has fought all of her life. She maintains an active practice as a labor and employment attorney and was chair of the…
UTHealth Houston opens recruitment in RISE-UP clinical drug trial for people with sickle cell anemia
A medication that appeared to stabilize the function and shape of red blood cells in an earlier study for patients with sickle cell disease is now part of a Phase III clinical trial that is open for enrollment at UTHealth…
At the Bedside: Nurse with sickle cell disease joins clinical drug trial and finds energy she’s never had before
The day that Dorcas Osho and her parents moved to the United States, just one day after her fifth birthday, she began screaming in pain. Her parents scrambled to help their daughter and rushed her to a children’s hospital, where…
Rios elected to Sigma Xi Honor Society
Adan Rios, MD, professor in the Department of Internal Medicine, has been elected as a member of the Sigma Xi Honor Society, and as a board member for the society’s Texas Medical Center Chapter. “I have been arduously working for years on…
New CLL meds: Improved survival rates, 1990-2018
Binsah George, MD, was quoted in an MDEdge article about how medications to treat chronic lymphocytic leukemia are improving the survival rate of patients.
CPRIT grant funds study of oncological pain management
Nonpharmaceutical approach Enabling self-managed, nonpharmaceutical pain management for patients receiving cancer treatments is the goal of a new study at Cizik School of Nursing at UTHealth Houston funded by a $1 million grant from the Cancer Prevention and Research Institute of…
2022 ASCO Meeting
Fellows Arthi Sridhar (left) and Binoy Yohannan (right) at the 2022 ASCO meeting in Chicago, IL, with their poster presentation, “Renal Cell Carcinoma in Renal Transplant Recipients: Is There a Role for Screening?”